biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a202-01a-11d-a14k-09
biospecimen_aliquot__bcr_aliquot_uuid	e6feb69a-8827-4d43-94aa-036cf5150549
biospecimen_aliquot__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108476688
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-04-26
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a14k
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	4.81
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	53.40
biospecimen_analyte__a260_a280_ratio	1.89
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a202-01a-11d
biospecimen_analyte__bcr_analyte_uuid	2d9468a4-0993-4d07-8c0d-7db49e0933d5
biospecimen_analyte__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_analyte__concentration	0.18
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a202
biospecimen_diagnostic_slides__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	8cecdb74-5e6f-4ce8-b52c-a89e574f38fb
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a202
biospecimen_normal_control__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_portion__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_portion__bcr_portion_barcode	tcga-bh-a202-01a-11
biospecimen_portion__bcr_portion_uuid	6d3c4d23-baf6-4c71-8866-d22c22a910f6
biospecimen_portion__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_portion__date_of_creation	2011-04-08
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a202-01a-11d
biospecimen_protocol__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_sample__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_sample__bcr_sample_uuid	8fa798fe-f032-4d77-b362-06261db78e6d
biospecimen_sample__days_to_collection	62
biospecimen_sample__initial_weight	200
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a202.57323ae5-3efe-4492-8522-d9a6db3f1be0.pdf
biospecimen_sample__pathology_report_uuid	57323ae5-3efe-4492-8522-d9a6db3f1be0
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_shipment_portion__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	c393111f-c4f6-473b-a396-05dd90d531e1
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17k
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-bh-a202-01a-21-a17k-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
biospecimen_slide__bcr_sample_barcode	tcga-bh-a202-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a202-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	c8671f7f-1c8e-46f2-bb75-89786eda4c8e
biospecimen_slide__image_file_name	tcga-bh-a202-01a-01-tsa.c8671f7f-1c8e-46f2-bb75-89786eda4c8e.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	10
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	40
biospecimen_slide__percent_tumor_cells	50
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a202
biospecimen_tumor_sample__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
clinical_drug__bcr_drug_barcode	tcga-bh-a202-d64230
clinical_drug__bcr_drug_uuid	0d4881e9-ae20-4588-920d-75e5d8ab81ed
clinical_drug__bcr_patient_barcode	tcga-bh-a202
clinical_drug__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
clinical_drug__form_completion_date	2014-8-27
clinical_drug__pharmaceutical_therapy_drug_name	carboplatin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	169
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	47
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-bh-a202-f64226
clinical_follow_up__bcr_followup_uuid	32acc3f7-b74b-4080-8297-329edc6a00d5
clinical_follow_up__bcr_patient_barcode	tcga-bh-a202
clinical_follow_up__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-8-27
clinical_follow_up__last_contact_days_to	795
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	60
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage ii
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left
clinical_patient__bcr_patient_barcode	tcga-bh-a202
clinical_patient__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
clinical_patient__birth_days_to	-22052
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__first_surgical_procedure_other	segmental mastectomy with sentinel lymph node biopsy
clinical_patient__form_completion_date	2011-9-8
clinical_patient__gender	female
clinical_patient__her2_status_by_ihc	positive
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	22
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	4
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__patient_id	a202
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	other
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a202
clinical_radiation__bcr_patient_uuid	e7a00d67-2c26-4d1f-bd17-35f659e88bc1
clinical_radiation__bcr_radiation_barcode	tcga-bh-a202-r64232
clinical_radiation__bcr_radiation_uuid	2384cc18-9597-4204-8ad1-330a44034ac4
clinical_radiation__form_completion_date	2014-8-27
clinical_radiation__radiation_adjuvant_fractions_total	25
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	231
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	182
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	6100
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A202-01A-11D-A14K-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A202-01A-11D-A14K-09.bed.meta
manually_curated__id	tcga-bh-a202-01a-11d-a14k-09
manually_curated__md5sum	70eb1a7ea41681f069920ebd9c398a07
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	e6feb69a-8827-4d43-94aa-036cf5150549
manually_curated__tumor_tag	brca
